Vontobel Holding
BCAB icon

Vontobel Holding’s BioAtla BCAB Stock Holding History

Vontobel Holding’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-320
Closed -$9.46K – 1094
2024
Q4 		$9.46K Hold
320
– – ﹤0.01% 1092
2024
Q3 		$28.2K Buy
+320
New +$26.8K ﹤0.01% 1069
2024
Q1 		– Sell
-14,121
Closed -$1.74M – 1097
2023
Q4 		$1.74M Sell
14,121
-183
-1% -$15.9K 0.01% 459
2023
Q3 		$1.22M Buy
14,304
+2,991
+26% +$381K 0.01% 540
2023
Q2 		$1.7M Buy
11,313
+270
+2% +$46.4K 0.01% 474
2023
Q1 		$1.48M Buy
11,043
+8,094
+274% +$1.46M 0.01% 487
2022
Q4 		$1.22M Buy
+2,949
New +$1.22M 0.01% 523

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Vontobel Holding's BCAB Position: Q1 2025 in Review

Vontobel Holding sold out of BioAtla (BCAB) in Q1 2025, closing a stake of 320 shares — an estimated $9.46K sold.

Vontobel Holding first reported a position in BCAB in Q4 2022 and held it in 7 quarters. The position peaked at $1.74M in Q4 2023. 41 funds tracked by Wall St. Rank hold BCAB as of Q1 2025.

  • Vontobel Holding reported no remaining BioAtla position as of Q1 2025 after selling out during the quarter.
  • Vontobel Holding sold 320 BioAtla shares in Q1 2025, an estimated $9.46K.
  • Vontobel Holding first reported a position in BioAtla in Q4 2022 and held it in 7 quarters.
  • Vontobel Holding's BioAtla position peaked at $1.74M in Q4 2023.
  • 41 funds tracked by Wall St. Rank held BioAtla as of Q1 2025.

Based on Vontobel Holding's 13F filing for Q1 2025, filed 28 Apr 2025.